Health
Pfizer vaccine can neutralise coronavirus variants first reported in UK, South Africa: Study – Hindustan Times
The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants.
The Covid-19 vaccine co-developed by the American pharmaceutical giant Pfizer and the German biotechnology company BioNTech can neutralise variants of the novel coronavirus that were first reported in the UK and South Africa, a new study suggests.
The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants carrying the N501Y and E484K mutations.
According to the scientists, including those from the University of Texas in the US, these…
-
General23 hours agoWondering about winter | The Spectator Australia
-
General22 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash
-
Noosa News20 hours agoThis 42-Kilometre Walking Trail on the NSW North Coast Weaves Through Ancient Rainforest, Volcanic Mountains and Spectacular Waterfalls
-
Noosa News22 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland